Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
emactuzumab
×
Clear all
Filters
3
NCT05417789
2026-02-02
TANGENT
SynOx Therapeutics Limited
Phase 3
Active not recruiting
128 enrolled
NCT03768063
2026-01-29
IMbrella B
Hoffmann-La Roche
Phase 3
Active not recruiting
1,000 enrolled